Outcomes of Fully Robotic Recipient Living Donor Liver Transplant in Relation to the Open Approach

医学 肝移植 倾向得分匹配 外科 机械人手术 肝病 移植 非酒精性脂肪性肝炎 内科学 非酒精性脂肪肝 疾病 脂肪肝
作者
Dieter Broering,Yasser Elsheikh,Massimo Malagó,Yasir Alnemary,Saleh Alabbad,Markus U. Boehnert,Dimitri Aristotle Raptis
出处
期刊:Transplantation [Wolters Kluwer]
被引量:1
标识
DOI:10.1097/tp.0000000000005109
摘要

Background. Over the past 20 y, robotic surgery has entered nearly all surgical disciplines, aiming to improve patient outcomes. Liver transplantation has evolved with these advancements, and fully robotic liver transplants represent the latest innovation in this field. This study reports on the world’s first series of fully robotic recipient liver transplants from robotic living donors, comparing them with matched cases from the standard open transplant approach. Methods. A case-control study was conducted at our center from August to December 2023. Patient selection criteria for robotic recipient liver transplantation included a Model for End-stage Liver Disease score of ≤25, specific anatomical characteristics, and logistics. A propensity score analysis with a 1:4 matching ratio was used. Results. The study analyzed 10 fully robotic living donor and robotic recipient liver transplant pairs with a median donor age of 29 y and a recipient age of 61 y. The main indication for transplantation was nonalcoholic steatohepatitis (6/10). There was 1 robotic to open conversion, and the median operation time was 10 h, with a median hospital stay of 13 d, shorter than the 18 d in the open group. Three recipients experienced a complication, and there was no mortality. Conclusions. The first-ever series of fully robotic living donor recipient liver transplants showed encouraging initial results with a markedly reduced hospital stay. The ultimate goal is to refine the technique to offer robotic liver transplants to the majority of recipients, overcoming the current selection criteria. Further research and a planned randomized controlled trial will aim to confirm these results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎应助搞怪代荷采纳,获得10
1秒前
2秒前
科目三应助飘逸丸子采纳,获得10
3秒前
云游归尘发布了新的文献求助10
3秒前
3秒前
4秒前
量子星尘发布了新的文献求助10
4秒前
5秒前
5秒前
sang完成签到,获得积分10
6秒前
宁宁宁发布了新的文献求助10
6秒前
8R60d8完成签到,获得积分0
7秒前
三火完成签到,获得积分10
7秒前
8秒前
慕青应助爱听歌的从筠采纳,获得10
8秒前
sang发布了新的文献求助10
8秒前
8秒前
mob发布了新的文献求助10
9秒前
10秒前
cc完成签到,获得积分10
11秒前
LLL完成签到,获得积分10
11秒前
依沫完成签到,获得积分10
11秒前
11秒前
bnuli发布了新的文献求助10
12秒前
三火发布了新的文献求助10
12秒前
淡然绾绾发布了新的文献求助10
12秒前
13秒前
搞怪代荷发布了新的文献求助10
14秒前
科研废物完成签到,获得积分10
15秒前
奔跑的黑熊仔应助YAN采纳,获得20
16秒前
16秒前
16秒前
Rick.发布了新的文献求助200
18秒前
18秒前
量子星尘发布了新的文献求助10
18秒前
18秒前
懒洋洋完成签到 ,获得积分10
19秒前
20秒前
娃哈哈发布了新的文献求助10
21秒前
邱智毅完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6063379
求助须知:如何正确求助?哪些是违规求助? 7895929
关于积分的说明 16314746
捐赠科研通 5206753
什么是DOI,文献DOI怎么找? 2785470
邀请新用户注册赠送积分活动 1768125
关于科研通互助平台的介绍 1647508